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Abstract6
The magnetic targeted drug delivery system of Avilés, Ebner and Ritter, which uses7
high gradient magnetic separation (HGMS) is considered. In that model large fer-8
romagnetic particles are used as seeds to aid collection of multiple domain nanopar-9
ticles (radius ≈ 200 nm). Here, in contrast, single domain magnetic nanoparticles10
(radius in 20–100 nm) are considered and the Langevin function is used to describe11
the magnetization. Simulations based on this model were performed using the open12
source C++ finite volume library OpenFOAM. The simulations indicate that use of13
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1 Introduction19
Magnetic nanoparticles continue to offer much promise as carriers in drug20
targeting systems [1, 2]. That the force exerted on an individual particle21
is determined by the gradient of the field and not simply the field is well22
known [1, 3–8]. As has been pointed out by several authors [3–8] this may23
inhibit the targeting, solely by means of external permanent magnets, of ar-24
eas deep within the body. With this in mind, the implanting of ferromagnetic25
materials, such as wires, seeds or stents, in blood vessels has been proposed26
by some authors [4–7], in order to create large localised gradients within the27
vessels. Berry [2] has suggested that magnetic nanoparticles with radius of the28
order of 50 nm may have advantages as drug carriers, and here these are taken29
as the carriers. For a related problem, Furlani and Furlani [9] have developed30
a model for which it was possible to obtain an analytical expression for the31
behaviour of multifunctional particles. In contrast, the approach taken here is32
largely numerical in that while the magnetic field is obtained from an analyti-33
cal expression both the fluid flow and resulting particle trajectories are obtain34
using OpenFOAM a finite volume simulation C++ library.35
2 Outline of Model36
The model of Avilés, Ebner and Ritter [10], is considered, which uses ferro-37
magnetic material, to create a localised field gradient, at the desired site in38
the body. This ferromagnetic material, termed seed, has a radius of the or-39
der of 1µm. The model treats the behaviour of magnetic particles under the40
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Fig. 1. Schematic diagram of the control volume, CV, used in determining the
capture radius, λc, of the superparamagnetic single-domain nanoparticles.
influence of Stokes drag and the magnetic force. The Stokes drag is given by41
~Fs = 6π ηbRp (~vb − ~vp), (1)
where ηb is the viscosity of the blood, Rp the radius of the particle, and ~vb42
and ~vp are the velocities of the blood and the particle respectively. The blood43
velocity, ~vb, is determined by solving the appropriate Navier-Stokes equations.44
The magnetic force is determined by45
~Fm = (~m · ∇) ~B, (2)
where ~B is the resulting magnetic flux density (due to the external magnetic46
field ~H and the presence of the seed) and ~m is the magnetic moment of the47
particle. We follow Avilés et al. [10] and consider the effect of a magnetisable48
seed placed in the blood flow as indicated in Fig. 1. The magnetisation of the49
seed can be calculated from50
Mseed = 2αseedH0, (3)
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where αseed is the demagnetising factor for an infinitely long cylinder in a51










where χseed,0 and Mseed,s are the zero field susceptibility and saturation mag-53
netisation of the ferromagnetic seed respectively, and H0 is the magnitude of54
the externally applied homogeneous field. In the model of Avilés et al. mi-55
croparticles were considered, where the axis of the moment ~m lay along that56
of ~B, and the magnetisation increased with applied field, after accounting for57
demagnetising. In contrast, nanoparticles of diameter < 100 nm are typically58
superparamagnetic single domains. Accounting for thermal agitation, their59
average magnetisation is given by the Langevin function [3, 8, 11, 12]60









where µ0 is the magnetic permeability of free space, ωfm,p is the volume fraction62
of ferromagnetic material in the particle, Vp is the particle volume, Mfm,p,s the63
(volume) saturation magnetisation, k is Boltzmann’s constant and T is the64
absolute temperature, so that ~m can be written as65




The value of ~B, required to calculate the magnetic force as given by Eqs. (2)66
and (7), is calculated from solving the Laplace equation as outlined in Sec-67
tion 4.68
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3 Blood flow — the Navier-Stokes equations69
Following the notation of Avilés et al. [10] we write the blood velocity ~vb and70
the pressure P for a incompressible, Newtonian fluid at steady state. We have71
the continuity equation72
∇ · ~vb = 0, (8)
and the Navier-Stokes equation73
ρb[(~vb · ∇~vb)] = ∇P + ηb∇
2~vb, (9)
where ρb is the density of the blood. To solve Eqs. (8) and (9), a uniform inlet74





















where u0 is the inlet blood velocity. Non-slip boundary conditions are applied76
at the seed surface in contact with the bloodstream. In addition, symmetry77
boundary conditions are applied at the upper and lower CV boundaries to78
maintain the constant flow profile and atmospheric pressure is assumed at79
the outlet of the CV to satisfy the boundary condition on pressure. Other80
assumptions include isothermal, single-phase, incompressible, Newtonian fluid81
flow as used by Avilés et al. [10].82
4 The magnetic force — the scalar magnetic potential83
The second part of this model involves the scalar magnetic potential, φ, which84
satisfies the Laplace equation over two con-joined regions: inside the seed and85
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outside the seed. From the scalar potential, we can obtain the magnetic flux86
density, ~B, as required, through87
~B = −µ0∇φ. (11)
Thus for the two regions, within the seed and the rest of the space we have88
respectively ~Bseed and ~Bspace as89
~Bseed = −µ0(~mseed + ~H0 −∇φseed), (12)
~Bspace = −µ0( ~H0 −∇φspace), (13)
where φseed and φspace represent the scalar magnetic potential within the seed90
and in the space outside the seed respectively. Here ~mseed is the induced mag-91






















where θ is the angle from the positive x-axis. Laplace’s equation for the scalar94
potential is solved analytically by separation of variables. Firstly, the normal95
component of the magnetic flux and potential are both assumed to be con-96
tinuous across the seed-blood interface. Secondly, the scalar potential should97




(x cos θ+ y sin θ), φspace = H0
µr − 1
µr + 1
x cos θ + y sin θ
x2 + y2
, (15)
where µr is the relative permeability of the ferromagnetic seeds.99
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5 Velocity equations, streamlines and capture cross section100
Considering the forces, the velocity equations can be obtained through com-101
bining the hydrodynamic and magnetic velocities [10],102






∇( ~Hf · ~Hf), (16)
where Rseed is the seed radius and ~Hf is the total magnetic field at the location103
of the magnetic drug carrier particle and is given by104
~Hf = ~H0 −∇φspace. (17)
Here the magnitude of the total magnetic field Hf is given by
√



























The volume fraction of ferromagnetic material ωfm,p in the magnetic drug107
carrier particle is related to its weight fraction xfm,p through [5]108
ωfm,p =
xfm,p
xfm,p + (1 − xfm,p)ρfm,p/ρpol,p
, (20)
where ρfm,p is the density of the ferromagnetic material in the magnetic drug109
carrier particle and ρpol,p is the density of the polymer material in the magnetic110
drug carrier particle.111










where ψ is the stream function, and vp,x and vp,y are the components of ~vp115
which are given by Eq. (16). The system performance of this model is calcu-116





where yc is the capture radius of the ferromagnetic seed. The capture radius,118
yc, is defined by the location of the streamline at the entrance to the CV of119
the last magnetic drug carrier particle captured to the seed. All calculations120
were performed using the open-source software finite volume library Open-121
FOAM [13].122
6 Results and Discussions123
In this simulation iron is used as the magnetic drug carrier particle and SS 409124
is used as the seed ferromagnetic material. The streamline functions for the125
capture of nanoparticles are presented in Fig. 2 for particle radius Rp = 50 nm,126
containing 40wt% iron (xfm,p = 0.4), under the influence of homogenous mag-127
netic field µ0H0 oriented perpendicularly to the flow (θ = π/2) with magni-128
tudes of 0.0 to 0.6 T. In this a single SS409 ferromagnetic seed, with 1µm129
radius is located in the CV. The resulting capture cross-section, λc, is calcu-130
lated and presented in Fig. 3 for 50 nm particles, as a function of the magnetic131
field strength µ0H0. In the model the magnetisation of the individual nanopar-132
ticles is taken as the average value given by the Langevin function. The values133
of the capture cross-section predicted through use of the Langevin function134
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(a) µ0H0 = 0.0 T (b) µ0H0 = 0.2 T
(c) µ0H0 = 0.4 T (d) µ0H0 = 0.6 T
Fig. 2. Streamlines indicating the trajectories of the single domain nanoparticles,
calculated using OpenFOAM, as they traverse the control volume for different mag-
nitudes of the externally applied magnetic field, ~H0.
are significantly larger (see Fig. 3) than would result from the large parti-135
cle approach taken by Avilés et al.. Beyond a field of ≈0.7T, for the material136
used in this simulation, the carrier particle magnetisation is saturated for both137
models, leading to identical results.138
In order to calculate the blood velocity an uniform inlet velocity of 0.1 cm/s139
is applied to the model. Other important system and parameters of the fer-140
romagnetic materials that are used in the magnetic drug carrier particles and141
for the seeds are given in Table 1.142
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Fig. 3. Capture cross section, λc, plotted as a function of the applied magnetic
field strength, µ0H0, calculated using ( ) the Langevin function as appropriate
for single domain particles and ( ) without Langevin function as appropriate for
multiple domain particles.
Property Value SI Unit Property Value SI Unit
ρb 1 040.0 kgm
−3 χseed,0 1 000
ηb 0.002 kgm
−1 s−1 Mseed,s 1 397 000 Am
−1
u0 0.001 m s
−1 Mfm,p,0,s 1 735 000 Am
−1
µ0H0 0.0–0.8 kg s
−2 A−1 Rs 1.0 × 10
−6 m
xfm,p 0 Rp 50 × 10
−9 m
ρfm,p 7 850 kgm




Values of system and material parameters used in the simulation.
7 Conclusions143
The model of Avilés, Ebner and Ritter has been considered for collecting144
single domain magnetic drug carrier nanoparticles. Here the Langevin function145
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is used to calculate the expected value of the nanoparticle magnetisation.146
Magnetic flux density ~B is calculated analytically by using the separation of147
variable solution and the blood velocity ~vb is obtained from the Navier-Stokes148
equation using the finite volume library OpenFOAM. The simulations indicate149
that use of the Langevin function predicts greater collection efficiency than150
might be otherwise expected.151
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